N/A N=47 Family Focused Community Program to Prevent Type 2 Diabetes in Peripubertal Youth
Pediatric Obesity
Primary: Change in Percentage Overweight — 1.92; 1.91 change in percent overweight
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=5,127 Community Collaboration to Advance Racial/Ethnic Equity in CRC Screening
Colorectal Cancer
Primary: CRC Screening Completion Rates — 550; 751 Participants — p=0.05
Phase 3 N=1,015 Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort II)
Vasomotor Symptoms · Menopausal Symptoms
Primary: Mean Change in Weekly Frequency of Moderate to Severe Vasomotor Symptoms (VMS) From Baseline to Week 4 and Week 12 -- (Efficacy Study Part) — -39.77; -40.11; -31.82…
N/A N=120 Heart Rate Variability Biofeedback for Substance Use Disorder: A Randomized Clinical Trial
Substance Use Disorders
Primary: Heart Rate Variability Biofeedback Engagement — 15; 0 Participants
Phase 1 N=247 A Study of LY3039478 in Participants With Advanced Cancer
Neoplasms · Neoplasm Metastasis · Lymphoma
Primary: Part A and F: Number of Participants With Dose Limiting Toxicities (DLTs) — 0; 0; 0; 1 Participants
Phase 2 N=88 A Study to Evaluate the Safety and Efficacy of Multiple Doses of LT3001 Drug Product in AIS Subjects
Acute Ischemic Stroke
Primary: The Proportion of Subjects With Adverse Events (AEs), Judged to be Probably or Definitely Related to the Investigational Product (IP), Within 90 Days After the First IP…
Phase 3 N=833 A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a COVID-19 mRNA Vaccine in Adults Aged 50 Years and Above
Respiratory Syncytial Virus Infections
Primary: Adjusted Geometric Mean Titers (GMT) of Respiratory Syncytial Virus-A (RSV-A) Neutralizing Titers at 1 Month After the RSVPreF3 OA Vaccination — 7885.8; 8803.4 Titers
N/A N=156 A Multi-center Outcomes Clinical Study of the PyroTITAN™ HRA Shoulder Implant in Humeral Head Resurfacing
Arthritis
Primary: Device Survival — 85.97 percentage of shoulders
N/A N=155 mHealth for Young Adult Cancer Survivors
Survivorship · Cancer · Psychological Well-Being
Primary: Retention — 74; 72 Participants
N/A N=5,176 Framing Clinical Trial Enrollment for Patients With Peripheral Artery Disease
Peripheral Artery Disease
Primary: Enrollment in GAMEPAD Intervention Study — 39; 45 Participants
N/A N=131 Spinal Pain and Autonomic Responses to Chiropractic Care
Neck Pain
Primary: Change in Heart Rate Variability — 843; 887 ms
N/A N=2,140,403 A Study to Learn About the Effects of Medicines That Help in Thinning the Blood in People With Atrial Fibrillation (AF) Between 2016 and 2020 in France
Atrial Fibrillation
Primary: Incidence Rate (Per 1000 Participant-years) of Stroke in Non-valvular Atrial Fibrillation (AF) Participants Exposed to Oral Anticoagulation (OAC) and Unexposed to OAC…
Phase 2 N=40 A Study of Fisetin to Treat Carpal Tunnel Syndrome
Carpal Tunnel Syndrome
Primary: Change in Boston Carpal Tunnel Syndrome (BCTQ) Score — -0.5 score on a scale
N/A N=26 Surgical Treatment of Post-surgical Mastectomy Pain Utilizing the Regenerative Peripheral Nerve Interface
Post-Mastectomy Chronic Pain Syndrome
Primary: Change in Pain Level — 6.9; 0.6; 4.4; 2.5 score on a scale
N/A N=123 Me & You-Tech: A Socio-Ecological Solution to Teen Dating Violence for the Digital Age
Adolescent Behavior · Interpersonal Relations · Domestic Violence
Primary: Number of Youth Who Perpetrated Any Type of Teen Dating Violence as Assessed by the Conflict in Adolescent Dating Relationships Inventory (CADRI) — 12; 15; 26; 59…